ASX Share rice
Sun 09 May 2021 - 06:03:pm (Sydney)

OSL Share Price

ONCOSIL MEDICAL LTDOSLPharmaceuticals, Biotechnology & Life Sciences

OSL Company Information

Name:

OncoSil Medical Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

15 Blue Street North Sydney NSW Australia 2060

Phone:

61 2 9223 3344

CFO & Company Sec.:

Mr. Karl David Pechmann

CEO, MD & Pres of EMEA:

Mr. Nigel Lange

Global Sales & Marketing Director:

Mr. Michael Warrener

Global Head of Manufacturing Operations:

Dr. David Charles James

Pres of US Operations:

Mr. Charles Rowland

Chief Medical Officer:

Dr. Ralph Peters

Head of Medical Affairs:

Mr. David Turner

Company Overview:

OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.

OSL Share Price Information

Shares Issued:

807.34M

Market Capitalisation:

$73.47M

Revenue (TTM):

$2.22M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.014

Profit Margin:

-2.5304

Operating Margin (TTM):

$-2.68

Return On Assets (TTM):

$-0.27

Return On Equity (TTM):

$-0.46

Quarterly Revenue Growth (YOY):

-0.469

Gross Profit(TTM):

$2.76M

Diluted Earnings Per Share (TTM):

$-0.007

OSL CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-20,721

Change To Liabilities:

$1.01M

Total Cashflow From Investing Activities:

$-20,721

Net Borrowings:

$-94,532

Net Income:

$-4,261,895

Total Cash From Operating Activities:

$-4,456,079

Depreciation:

$149.29K

Sale Purchase Of Stock:

$19.10M

Capital Expenditures:

$20.72K

OSL Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-4,261,900

Net Income:

$-4,261,900

Operating Income:

$-4,251,900

Interest Expense:

$861

Total Revenue:

$2.96M

OSL Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$2.16M

Total Stockholder Equity:

$21.90M

Other Current Liabilities:

$208.40K

Total Assets:

$24.06M

Common Stock:

$70.14M

Other Current Assets:

$69.21K

Retained Earnings:

$-51,864,385

Cash:

$21M

Total Current Liabilities:

$2.16M

Short-Term Debt:

$26.56K

Property - Plant & Equipment:

$138.37K

Net Tangible Assets:

$21.90M

Total Current Assets:

$23.92M

Net Receivables:

$2.81M

Short-Term Investments:

$138.37K

Accounts Payable:

$1.36M

Short-Term Investments:

$138.37

Non Current Liabilities Total:

$0

OSL Share Price History

OSL News

09 Mar, 2021
The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...
09 Dec, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
11 Sep, 2020
The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...
30 May, 2020
Whilst it may not be a huge deal, we thought it was good to see that the OncoSil Medical Limited (ASX:OSL...